Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 19Unknown 5Terminated 4Recruiting 4Active not recruiting 4Withdrawn 2Not yet recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2

Conditions

Polycystic Ovary Syndrome 2Breast Neoplasms 2Hyperandrogenism 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Interventional × Estradiol × Clear all
NCT01428245 2020-12-30

JCM026

University of Virginia

Phase NA Terminated
3 enrolled 4 charts

Polycystic Ovary Syndrome

NCT01083641 2019-12-09

Estrogen for Triple Negative Breast Cancer

University of Wisconsin, Madison

Phase 2 Terminated
17 enrolled 10 charts
Breast

Breast Neoplasms

NCT01428193 2018-06-04

Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

University of Virginia

Phase NA Terminated
4 enrolled 5 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT00661531 2017-04-12

Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy

Georgetown University

Phase 2 Terminated
11 enrolled 8 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡